Blog
Blog by Alicia Gailliez, Business Development Manager, One Nucleus
Guest blog post by Chris Cooper, Scientific Specialist II, Immunotoxicology & Immunology, Labcorp Early Development Laboratories Ltd
Guest blog by Dave Mead, Director of Business Development, Isogenica Limited
I recently joined One Nucleus ’ BioWednesday panel to debate whether using Government R&D incentives are worth it.
1 in 4 people in England will experience a mental health problem of some kind each year (The Adult Psychiatric Morbidity Survey, 2007). The more we talk about mental health the more we break down the stigma and create a safe place for people to speak out about how they are feeling. Mental health problems can affect individuals very differently and be completely invisible to others.
Tony Jones, CEO & Jasmin Bannister, Events & Communications Administrator - One Nucleus
“Good company in a journey makes the way seem shorter”
Hanna Beaumont FIRM, Director, Science Technology, Partners&
Safety in the lab, working from home, employment law, contract disputes, Covid... company directors are now exposed to unprecedented liability for actions and decisions they make on behalf of their business. This means direct exposure of the personal assets of your board members and key decision makers – including NEDs.
Tony Jones, Chief Executive Officer, One Nucleus